DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Chanan-Khan A, Cramer P, Demirkan F, Fraser G, Silva RS, Grosicki S. et al.
Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): A randomised, double-blind, phase 3 study.
Lancet Oncol 2016;
17: 200-11
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.